Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20063342HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020742HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20069226HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20069227HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020743HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20015002HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20015003HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20021968HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020584HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20022100HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TCGA Plot Options
Drug Information
GeneCD274
DrugBank IDDB09035
Drug NameNivolumab
Target IDBE0003441
UniProt IDQ9NZQ7
Regulation Typeinhibitor
PubMed IDs33807678
CitationsKyriakidis I, Vasileiou E, Rossig C, Roilides E, Groll AH, Tragiannidis A: Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. J Fungi (Basel). 2021 Mar 5;7(3). pii: jof7030186. doi: 10.3390/jof7030186.
GroupsApproved
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBLCHEMBL2108738